The SAS System

The CONTENTS Procedure

Data Set Name TRAINING.SIMULATEDDRUGS01 Observations 3112
Member Type DATA Variables 317
Engine V9 Indexes 0
Created Sunday, November 09, 2014 10:56:32 PM Observation Length 2560
Last Modified Sunday, November 09, 2014 10:56:32 PM Deleted Observations 0
Protection   Compressed NO
Data Set Type   Sorted NO
Label Simulated Psychostimulant Drugs Sales Data 01 - WIDE    
Data Representation WINDOWS_64    
Encoding wlatin1 Western (Windows)    

Engine/Host Dependent Information
Data Set Page Size 16384
Number of Data Set Pages 522
First Data Page 3
Max Obs per Page 6
Obs in First Data Page 2
Number of Data Set Repairs 0
Filename I:\bokhari\fb_research\analysis\adhd\training\data\simulateddrugs01.sas7bdat
Release Created 9.0301M1
Host Created X64_7PRO

Variables in Creation Order
# Variable Type Len Format Informat Label
1 fips Char 5 $5. $5. 5Digit Fips State-County Code, Character
2 stabr Char 2 $2. $2. State Name Abbreviation
3 year Num 8 BEST8. BEST8. Year
4 msac Char 4     4Digit MSA/PMSA Code, Character
5 cntyst Char 30 $30. $30. County Name W/State Abbrev
6 cenregn Char 13     Census Region Name
7 cenregc Num 8     Census Region Code
8 cendivn Char 18     Census Division Name
9 cendivc Num 8     Census Division Code
10 msapmsa99c Num 8     MSA/PMSA Code 1999
11 poptot Num 8     Total Population in 1000s
12 kids0t4 Num 8     Children (Age 0 to 4)
13 kids5t19 Num 8     Children (Age 5 to 19)
14 kids Num 8     Children Aged 5-19
15 pcpi Num 8     Per Capita Personal Income (Real 2000 $s)/1000)
16 mds Num 8     Total MDs in 1000s (MDTPC)
17 caiddrugs Num 8     Amount Reimbured for Drugs by Medicaid
18 mcaidenrollees Num 8     Medicaid Enrollees in State (Census Estimates)
19 lncaiddrugs Num 8     Log (Total Amount Reimbured for Drugs by Medicaid)
20 lnmcaidenrollees Num 8     Log(Medicaid Enrollees in State (Census Estimates))
21 lnpop Num 8      
22 lnkids Num 8      
23 lnmds Num 8      
24 t1 Num 8     Time (t1): 1 is year 1999
25 t2 Num 8     Time Sq (t2): 1 is year 1999
26 rr Num 8     Total Revenue (All Drugs)
27 y1 Num 8     y1: Total Revenue in MPH-IR
28 y2 Num 8     y2: Total Revenue in MPH-ER
29 y3 Num 8     y3: Total Revenue in MPH-OROS
30 y4 Num 8     y4: Total Revenue in MAS-IR
31 y5 Num 8     y5: Total Revenue in MAS-ER
32 y6 Num 8     y6: Total Revenue in DEX-IR
33 y7 Num 8     y7: Total Revenue in DEX-ER
34 y8 Num 8     y8: Total Revenue in OTH
35 yy1 Num 8     yy1: Total Revenue in MPH
36 yy2 Num 8     yy2: Total Revenue in MAS
37 yy3 Num 8     yy3: Total Revenue in DEX
38 yy4 Num 8     yy4: Total Revenue in OTH
39 r1 Num 8     r1: Sales of Ritalin (real 2000 $s)
40 r2 Num 8     r2: Sales of Methylin (real 2000 $s)
41 r3 Num 8     r3: Sales of Generic MPH-IR (real 2000 $s)
42 r4 Num 8     r4 : Sales of Ritalin SR/LA (real 2000 $s)
43 r5 Num 8     r5 : Sales of Metadate CD/ER (real 2000 $s)
44 r6 Num 8     r6 : Sales of Methylin ER (real 2000 $s)
45 r7 Num 8     r7 : Sales of Generic MPH-ER (real 2000 $s)
46 r8 Num 8     r8 : Sales of Concerta (real 2000 $s)
47 r9 Num 8     r9 : Sales of Adderall (real 2000 $s)
48 r10 Num 8     r10 : Sales of Generic MAS-IR (real 2000 $s)
49 r11 Num 8     r11 : Sales of Adderall XR (real 2000 $s)
50 r12 Num 8     r12 : Sales of Dexedrine (real 2000 $s)
51 r13 Num 8     r13 : Sales of Dextrostat (real 2000 $s)
52 r14 Num 8     r14 : Sales of Generic DEX-IR (real 2000 $s)
53 r15 Num 8     r15 : Sales of Dexedrine SR (real 2000 $s)
54 r16 Num 8     r16 : Sales of Generic DEX-ER (real 2000 $s)
55 r17 Num 8     r17: Sales of 17a,17b,17c,17d (real 2000 $s)
56 qq Num 8     Total Quantity (All Drugs)
57 q1 Num 8     q1: Qnty of Ritalin
58 q2 Num 8     q2: Qnty of Methylin
59 q3 Num 8     q3: Qnty of Generic MPH-IR
60 q4 Num 8     q4: Qnty of Ritalin SR/LA
61 q5 Num 8     q5: Qnty of Metadate CD/ER
62 q6 Num 8     q6: Qnty of Methylin ER
63 q7 Num 8     q7: Qnty of Generic MPH-ER
64 q8 Num 8     q8: Qnty of Concerta
65 q9 Num 8     q9: Qnty of Adderall
66 q10 Num 8     q10: Qnty of Generic MAS-IR
67 q11 Num 8     q11: Qnty of Adderall XR
68 q12 Num 8     q12: Qnty of Dexedrine
69 q13 Num 8     q13: Qnty of Dextrostat
70 q14 Num 8     q14: Qnty of Generic DEX-IR
71 q15 Num 8     q15: Qnty of Dexedrine SR
72 q16 Num 8     q16: Qnty of Generic DEX-ER
73 q17 Num 8     q17: Qnty of 17a,17b,17c,17d
74 po1 Num 8     po1: Price of Ritalin
75 po2 Num 8     po2: Price of Methylin
76 po3 Num 8     po3: Price of Generic MPH-IR
77 po4 Num 8     po4: Price of Ritalin SR/LA weighted by shares of revenues
78 po5 Num 8     po5: Price of Metadate CD/ER weighted by shares of revenues
79 po6 Num 8     po6: Price of Methylin ER
80 po7 Num 8     po7: Price of Generic MPH-ER
81 po8 Num 8     po8: Price of Concerta
82 po9 Num 8     po9: Price of Adderall
83 po10 Num 8     po10: Price of Generic MAS-IR
84 po11 Num 8     po11: Price of Adderall XR
85 po12 Num 8     po12: Price of Dexedrine
86 po13 Num 8     po13: Price of Dextrostat
87 po14 Num 8     po14: Price of Generic DEX-IR
88 po15 Num 8     po15: Price of Dexedrine SR
89 po16 Num 8     po16: Price of Generic DEX-ER
90 po17 Num 8     po17: Price of 17a,17b,17c,17d weighted by shares of revenues
91 lpo1 Num 8     lpo1: log Price of Ritalin
92 lpo2 Num 8     lpo2: log Price of Methylin
93 lpo3 Num 8     lpo3: log Price of Generic MPH-IR
94 lpo4 Num 8     lpo4: log Price of Ritalin SR/LA weighted by shares of revenues
95 lpo5 Num 8     lpo5: log Price of Metadate CD/ER weighted by shares of revenues
96 lpo6 Num 8     lpo6: log Price of Methylin ER
97 lpo7 Num 8     lpo7: log Price of Generic MPH-ER
98 lpo8 Num 8     lpo8: log Price of Concerta
99 lpo9 Num 8     lpo9: log Price of Adderall
100 lpo10 Num 8     lpo10: log Price of Generic MAS-IR
101 lpo11 Num 8     lpo11: log Price of Adderall XR
102 lpo12 Num 8     lpo12: log Price of Dexedrine
103 lpo13 Num 8     lpo13: log Price of Dextrostat
104 lpo14 Num 8     lpo14: log Price of Generic DEX-IR
105 lpo15 Num 8     lpo15: log Price of Dexedrine SR
106 lpo16 Num 8     lpo16: log Price of Generic DEX-ER
107 lpo17 Num 8     lpo17: log Price of 17a,17b,17c,17d weighted by shares of revenues
108 s1 Num 8     s1: Rel Share of Ritalin (in MPH-IR)
109 s2 Num 8     s2: Rel Share of Methylin (in MPH-IR)
110 s3 Num 8     s3: Rel Share of Generic MPH-IR (in MPH-IR)
111 s4 Num 8     s4: Rel Share of Ritalin SR/LA (in MPH-ER)
112 s5 Num 8     s5: Rel Share of Metadate CD/ER (in MPH-ER)
113 s6 Num 8     s6: Rel Share of Methylin ER (in MPH-ER)
114 s7 Num 8     s7: Rel Share of Generic MPH-ER (in MPH-ER)
115 s8 Num 8     s8: Rel Share of Concerta (in MPH-OROS)
116 s9 Num 8     s9: Rel Share of Adderall (in MAS-IR)
117 s10 Num 8     s10: Rel Share of Generic MAS-IR (in MAS-IR)
118 s11 Num 8     s11: Rel Share of Adderall XR (in MAS-ER)
119 s12 Num 8     s12: Rel Share of Dexedrine (in DEX-IR)
120 s13 Num 8     s13: Rel Share of Dextrostat (in DEX-IR)
121 s14 Num 8     s14: Rel Share of Generic DEX-IR (in DEX-IR)
122 s15 Num 8     s15: Rel Share of Dexedrine SR (in DEX-ER)
123 s16 Num 8     s16: Rel Share of Generic DEX-ER (in DEX-ER)
124 s17 Num 8     s17: Rel Share of 17a,17b,17c,17d (in OTH)
125 u1 Num 8     u1: Rel Share of MPH-IR in MPH
126 u2 Num 8     u2: Rel Share of MPH-ER in MPH
127 u3 Num 8     u3: Rel Share of MPH-OROS in MPH
128 u4 Num 8     u4: Rel Share of MAS-IR in MAS
129 u5 Num 8     u5: Rel Share of MAS-ER in MAS
130 u6 Num 8     u6: Rel Share of DEX-IR in DEX
131 u7 Num 8     u7: Rel Share of DEX-ER in DEX
132 u8 Num 8     u8: Rel Share of OTH in OTH
133 m1 Num 8     m1: Rel Share of MPH in MOLS
134 m2 Num 8     m2: Rel Share of MAS in MOLS
135 m3 Num 8     m3: Rel Share of DEX in MOLS
136 m4 Num 8     m4: Rel Share of OTH in MOLS
137 so1 Num 8     so1: Avg of s1 over fips within year
138 so2 Num 8     so2: Avg of s2 over fips within year
139 so3 Num 8     so3: Avg of s3 over fips within year
140 so4 Num 8     so4: Avg of s4 over fips within year
141 so5 Num 8     so5: Avg of s5 over fips within year
142 so6 Num 8     so6: Avg of s6 over fips within year
143 so7 Num 8     so7: Avg of s7 over fips within year
144 so8 Num 8     so8: Avg of s8 over fips within year
145 so9 Num 8     so9: Avg of s9 over fips within year
146 so10 Num 8     so10: Avg of s10 over fips within year
147 so11 Num 8     so11: Avg of s11 over fips within year
148 so12 Num 8     so12: Avg of s12 over fips within year
149 so13 Num 8     so13: Avg of s13 over fips within year
150 so14 Num 8     so14: Avg of s14 over fips within year
151 so15 Num 8     so15: Avg of s15 over fips within year
152 so16 Num 8     so16: Avg of s16 over fips within year
153 so17 Num 8     so17: Avg of s17 over fips within year
154 uo1 Num 8     uo1: Avg of u1 over fips within year
155 uo2 Num 8     uo2: Avg of u2 over fips within year
156 uo3 Num 8     uo3: Avg of u3 over fips within year
157 uo4 Num 8     uo4: Avg of u4 over fips within year
158 uo5 Num 8     uo5: Avg of u5 over fips within year
159 uo6 Num 8     uo6: Avg of u6 over fips within year
160 uo7 Num 8     uo7: Avg of u7 over fips within year
161 uo8 Num 8     uo8: Avg of u8 over fips within year
162 mo1 Num 8     mo1: Avg of m1 over fips within year
163 mo2 Num 8     mo2: Avg of m2 over fips within year
164 mo3 Num 8     mo3: Avg of m3 over fips within year
165 mo4 Num 8     mo4: Avg of m4 over fips within year
166 sr1 Num 8     sr1 : Abs Share (of revenue) of Ritalin
167 sr2 Num 8     sr2 : Abs Share (of revenue) of Methylin
168 sr3 Num 8     sr3 : Abs Share (of revenue) of Generic MPH-IR
169 sr4 Num 8     sr4 : Abs Share (of revenue) of Ritalin SR/LA
170 sr5 Num 8     sr5 : Abs Share (of revenue) of Metadate CD/ER
171 sr6 Num 8     sr6 : Abs Share (of revenue) of Methylin ER
172 sr7 Num 8     sr7 : Abs Share (of revenue) of Generic MPH-ER
173 sr8 Num 8     sr8 : Abs Share (of revenue) of Concerta
174 sr9 Num 8     sr9 : Abs Share (of revenue) of Adderall
175 sr10 Num 8     sr10 : Abs Share (of revenue) of Generic MAS-IR
176 sr11 Num 8     sr11 : Abs Share (of revenue) of Adderall XR
177 sr12 Num 8     sr12 : Abs Share (of revenue) of Dexedrine
178 sr13 Num 8     sr13 : Abs Share (of revenue) of Dextrostat
179 sr14 Num 8     sr14 : Abs Share (of revenue) of Generic DEX-IR
180 sr15 Num 8     sr15 : Abs Share (of revenue) of Dexedrine SR
181 sr16 Num 8     sr16 : Abs Share (of revenue) of Generic DEX-ER
182 sr17 Num 8     sr17 : Abs Share (of revenue) of 17a,17b,17c,17d
183 poz1 Num 8     poz1: Instrument for price of Ritalin
184 poz2 Num 8     poz2: Instrument for price of Methylin
185 poz3 Num 8     poz3: Instrument for price of Generic MPH-IR
186 poz4 Num 8     poz4: Instrument for price of Ritalin SR/LA
187 poz5 Num 8     poz5: Instrument for price of Metadate CD/ER
188 poz6 Num 8     poz6: Instrument for price of Methylin ER
189 poz7 Num 8     poz7: Instrument for price of Generic MPH-ER
190 poz8 Num 8     poz8: Instrument for price of Concerta
191 poz9 Num 8     poz9: Instrument for price of Adderall
192 poz10 Num 8     poz10: Instrument for price of Generic MAS-IR
193 poz11 Num 8     poz11: Instrument for price of Adderall XR
194 poz12 Num 8     poz12: Instrument for price of Dexedrine
195 poz13 Num 8     poz13: Instrument for price of Dextrostat
196 poz14 Num 8     poz14: Instrument for price of Generic DEX-IR
197 poz15 Num 8     poz15: Instrument for price of Dexedrine SR
198 poz16 Num 8     poz16: Instrument for price of Generic DEX-ER
199 poz17 Num 8     poz17: Instrument for price of 17(a,b,c,d)
200 lpoz1 Num 8     lpoz1: Instrument for (log) price of Ritalin
201 lpoz2 Num 8     lpoz2: Instrument for (log) price of Methylin
202 lpoz3 Num 8     lpoz3: Instrument for (log) price of Generic MPH-IR
203 lpoz4 Num 8     lpoz4: Instrument for (log) price of Ritalin SR/LA
204 lpoz5 Num 8     lpoz5: Instrument for (log) price of Metadate CD/ER
205 lpoz6 Num 8     lpoz6: Instrument for (log) price of Methylin ER
206 lpoz7 Num 8     lpoz7: Instrument for (log) price of Generic MPH-ER
207 lpoz8 Num 8     lpoz8: Instrument for (log) price of Concerta
208 lpoz9 Num 8     lpoz9: Instrument for (log) price of Adderall
209 lpoz10 Num 8     lpoz10: Instrument for (log) price of Generic MAS-IR
210 lpoz11 Num 8     lpoz11: Instrument for (log) price of Adderall XR
211 lpoz12 Num 8     lpoz12: Instrument for (log) price of Dexedrine
212 lpoz13 Num 8     lpoz13: Instrument for (log) price of Dextrostat
213 lpoz14 Num 8     lpoz14: Instrument for (log) price of Generic DEX-IR
214 lpoz15 Num 8     lpoz15: Instrument for (log) price of Dexedrine SR
215 lpoz16 Num 8     lpoz16: Instrument for (log) price of Generic DEX-ER
216 lpoz17 Num 8     lpoz17: Instrument for (log) price of 17(a,b,c,d)
217 lpoi1 Num 8     lpoi1: wt. avg. lpo1-lpo3 -- wt fixed shares (PI for MPH-IR)
218 lpoi2 Num 8     lpoi2: wt. avg. lpo4-lpo7 -- wt fixed shares (PI for MPH-ER)
219 lpoi3 Num 8     lpoi3: wt. avg. lpo8-lpo8 -- wt fixed shares (PI for MPH-OROS)
220 lpoi4 Num 8     lpoi4: wt. avg. lpo9-lpo10 -- wt fixed shares (PI for MAS-IR)
221 lpoi5 Num 8     lpoi5: wt. avg. lpo11-lpo11 -- wt fixed shares (PI for MAS-ER)
222 lpoi6 Num 8     lpoi6: wt. avg. lpo12-lpo14 -- wt fixed shares (PI for DEX-IR)
223 lpoi7 Num 8     lpoi7: wt. avg. lpo15-lpo16 -- wt fixed shares (PI for DEX-ER)
224 lpoi8 Num 8     lpoi8: wt. avg. lpo17(a,b,c,d) -- wt fixed shares (PI for OTH)
225 lpomi1 Num 8     lpomi1: wt. avg. lpoi1-lpoi3 -- wt fixed shares (PI for MPH)
226 lpomi2 Num 8     lpomi2: wt. avg. lpoi4-lpoi7 -- wt fixed shares (PI for MAS)
227 lpomi3 Num 8     lpomi3: wt. avg. lpoi6-lpoi7 -- wt fixed shares (PI for DEX)
228 lpomi4 Num 8     lpomi4: wt. avg. lpoi8-lpoi8 -- wt fixed shares (PI for OTH)
229 lpoi Num 8     lpoi: wt. avg. lpomii1-lpoii4 -- wt fixed shares (PI for ALL)
230 lpoii1 Num 8     lpoii1: wt. avg. lpo1-lpo3 -- wt actual shares (PI for MPH-IR)
231 lpoii2 Num 8     lpoii2: wt. avg. lpo4-lpo7 -- wt actual shares (PI for MPH-ER)
232 lpoii3 Num 8     lpoii3: wt. avg. lpo8-lpo8 -- wt actual shares (PI for MPH-OROS)
233 lpoii4 Num 8     lpoii4: wt. avg. lpo9-lpo10 -- wt actual shares (PI for MAS-IR)
234 lpoii5 Num 8     lpoii5: wt. avg. lpo11-lpo11 -- wt actual shares (PI for MAS-ER)
235 lpoii6 Num 8     lpoii6: wt. avg. lpo12-lpo14 -- wt actual shares (PI for DEX-IR)
236 lpoii7 Num 8     lpoii7: wt. avg. lpo15-lpo16 -- wt actual shares (PI for DEX-ER)
237 lpoii8 Num 8     lpoii8: wt. avg. lpo17(a,b,c,d) -- wt actual shares (PI for OTH)
238 lpomii1 Num 8     lpomii1: wt. avg. lpoii1-lpoii3 -- wt actual shares (PI for MPH)
239 lpomii2 Num 8     lpomii2: wt. avg. lpoii4-lpoii5 -- wt actual shares (PI for MAS)
240 lpomii3 Num 8     lpomii3: wt. avg. lpoii6-lpoii7 -- wt actual shares (PI for DEX)
241 lpomii4 Num 8     lpomii4: wt. avg. lpoii8-lpoii8 -- wt actual shares (PI for OTH)
242 lpoii Num 8     lpoii: wt. avg. lpomii1-lpoii4 -- wt actual shares (PI for ALL)
243 lpzi1 Num 8     lpzi1: wt. avg. lpz1-lpz3 -- wt fixed shares (PIz for MPH-IR)
244 lpzi2 Num 8     lpzi2: wt. avg. lpz4-lpz7 -- wt fixed shares (PIz for MPH-ER)
245 lpzi3 Num 8     lpzi3: wt. avg. lpz8-lpz8 -- wt fixed shares (PIz for MPH-OROS)
246 lpzi4 Num 8     lpzi4: wt. avg. lpz9-lpz10 -- wt fixed shares (PIz for MAS-IR)
247 lpzi5 Num 8     lpzi5: wt. avg. lpz11-lpz11 -- wt fixed shares (PIz for MAS-ER)
248 lpzi6 Num 8     lpzi6: wt. avg. lpz12-lpz14 -- wt fixed shares (PIz for DEX-IR)
249 lpzi7 Num 8     lpzi7: wt. avg. lpz15-lpz16 -- wt fixed shares (PIz for DEX-ER)
250 lpzi8 Num 8     lpzi8: wt. avg. lpz17(a,b,c,d) -- wt fixed shares (PIz for OTH)
251 lpzmi1 Num 8     lpzmi1: wt. avg. lpzi1-lpzi3 -- wt fixed shares (PIz for MPH)
252 lpzmi2 Num 8     lpzmi2: wt. avg. lpzi4-lpzi7 -- wt fixed shares (PIz for MAS)
253 lpzmi3 Num 8     lpzmi3: wt. avg. lpzi6-lpzi7 -- wt fixed shares (PIz for DEX)
254 lpzmi4 Num 8     lpzmi4: wt. avg. lpzi8-lpzi8 -- wt fixed shares (PIz for OTH)
255 lpzi Num 8     lpzi: wt. avg. lpzmii1-lpzii4 -- wt fixed shares (PIz for ALL)
256 lpzii1 Num 8     lpzii1: wt. avg. lpz1-lpz3 -- wt actual shares (PIz for MPH-IR)
257 lpzii2 Num 8     lpzii2: wt. avg. lpz4-lpz7 -- wt actual shares (PIz for MPH-ER)
258 lpzii3 Num 8     lpzii3: wt. avg. lpz8-lpz8 -- wt actual shares (PIz for MPH-OROS)
259 lpzii4 Num 8     lpzii4: wt. avg. lpz9-lpz10 -- wt actual shares (PIz for MAS-IR)
260 lpzii5 Num 8     lpzii5: wt. avg. lpz11-lpz11 -- wt actual shares (PIz for MAS-ER)
261 lpzii6 Num 8     lpzii6: wt. avg. lpz12-lpz14 -- wt actual shares (PIz for DEX-IR)
262 lpzii7 Num 8     lpzii7: wt. avg. lpz15-lpz16 -- wt actual shares (PIz for DEX-ER)
263 lpzii8 Num 8     lpzii8: wt. avg. lpz17(a,b,c,d) -- wt actual shares (PIz for OTH)
264 lpzmii1 Num 8     lpzmii1: wt. avg. lpzii1-lpzii3 -- wt actual shares (PIz for MPH)
265 lpzmii2 Num 8     lpzmii2: wt. avg. lpzii4-lpzii5 -- wt actual shares (PIz for MAS)
266 lpzmii3 Num 8     lpzmii3: wt. avg. lpzii6-lpzii7 -- wt actual shares (PIz for DEX)
267 lpzmii4 Num 8     lpzmii4: wt. avg. lpzii8-lpzii8 -- wt actual shares (PIz for OTH)
268 lpzii Num 8     lpzii: wt. avg. lpzmii1-lpzii4 -- wt actual shares (PIz for ALL)
269 d1 Num 8      
270 d2 Num 8      
271 d3 Num 8      
272 d4 Num 8      
273 d5 Num 8      
274 d6 Num 8      
275 d7 Num 8      
276 d8 Num 8      
277 d9 Num 8      
278 d10 Num 8      
279 d11 Num 8      
280 d12 Num 8      
281 d13 Num 8      
282 d14 Num 8      
283 d15 Num 8      
284 d16 Num 8      
285 d17 Num 8      
286 d18 Num 8      
287 d19 Num 8      
288 d20 Num 8      
289 d21 Num 8      
290 d22 Num 8      
291 d23 Num 8      
292 d24 Num 8      
293 d25 Num 8      
294 d26 Num 8      
295 d27 Num 8      
296 d28 Num 8      
297 d29 Num 8      
298 d30 Num 8      
299 d31 Num 8      
300 d32 Num 8      
301 d33 Num 8      
302 d34 Num 8      
303 d35 Num 8      
304 d36 Num 8      
305 d37 Num 8      
306 d38 Num 8      
307 d39 Num 8      
308 d40 Num 8      
309 d41 Num 8      
310 d42 Num 8      
311 d43 Num 8      
312 d44 Num 8      
313 d45 Num 8      
314 d46 Num 8      
315 d47 Num 8      
316 d48 Num 8      
317 d49 Num 8